FSA confirms plans to restrict TLP sales

clock

The Financial Services Authority (FSA) has hinted it may impose stricter regulatory requirements on firms recommending traded life policy investments (TLPIs) after issuing final guidance stating they should not be promoted to most retail investors.

The regulator said the guidance is an interim measure, and that it will soon consult on new rules imposing restrictions on the promotion of non-mainstream investments, including TLPIs, to retail investors. In November, the regulator announced its intention to act on unsuitable sales and promotions of TLPIs. It compared the products to 'ponzi schemes', language that attracted criticism from advisers and providers. Today, the FSA confirmed it does not believe the products should be marketed or sold to most investors after uncovering evidence of "significant problems with the way in whic...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Alternative Investments

Alternative investment fund managers regime reforms - a more proportionate approach?

Alternative investment fund managers regime reforms - a more proportionate approach?

'Dramatic difference' in firms' compliance burden under current regime

Romin Dabir
clock 03 June 2025 • 4 min read
Democratising finance: Alternatives and the role of financial advisers

Democratising finance: Alternatives and the role of financial advisers

The array of alternative investments is vast

J. Womack
clock 13 September 2023 • 3 min read

Andrew Aldridge: Vaccine roll out sees life science investment prospects shoot up

Andrew Aldridge

Andrew Aldridge
clock 11 March 2021 • 4 min read